In the quest to design vaccines that better help the body's immune system fight disease, scientists are always looking for ...

Downstream processing for mRNA manufacturing is currently too complex, but simplifying by using precipitation looks promising.

American researchers have now found a news type of mRNA vaccine to prevent the deadly disease. A team of US researchers have found that the vaccine is more scalable and adaptable to tackle ...

To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new study.

Abstract: While most data analysis of epigenetic modifications has focused on the transcriptional start site proximal region (TPR), the ... exhibit frequent and important interactions and are closely ...

One of the unmet needs in this field is the lack of a robust, sensitive, and multiplexed method for EV mRNA profiling. We established a new protocol using the NanoString low RNA input nCounter assay ...

“It's possible that in the next couple of years we'll start to see that that bottleneck get resolved, but it's also possible that it remains a pretty substantial bottleneck,” Curcios say ...

Moderna initiated the dosing for its innovative mRNA-4106 cancer therapy in a Phase 1 trial, signaling ongoing advancements in their oncology pipeline. However, the company's stock experienced a 3 ...

The first dose was administered at START San Antonio by Dr. Amita Patnaik who shared, "mRNA represents a bold new frontier in cancer immunotherapy, and we're proud to provide our patients access ...